Akoustis Technologies Inc expected to post a loss of 12 cents a share - Earnings Preview

Aktis Oncology

10/05/2024 15:03

* Akoustis Technologies Inc  AKTS.OQ   AKTS.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 13
for the period ending March 31 2024
    * The Huntersville North Carolina-based  company is expected
to
report a 16.3% increase in revenue to $8.553 million from $7.36
million a year ago, according to the mean estimate from 4
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Akoustis Technologies
Inc is
for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Akoustis
Technologies Inc is $1.00​, above​ its last closing price
of $0.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.19       -0.18      -0.19     Missed  -5.6
 Sep. 30 0001  -0.18                  -0.26             -44.4
 Jan. 1 0001   -0.16       -0.17      -0.21     Missed  -26.5​
 Jan. 1 0001   -0.20       -0.19      -0.20     Missed  -4.2
 ​​Jan.                    -0.25      -0.19     Beat    24
 1 0001                                                 
 Sep. 30 2022              -0.20      -0.28     Missed  -38.3​
 Jan. 1 0001               -0.19      -0.26     Missed  -34.5
 Mar. 31 2022  -0.23       -0.22      -0.22     Met     0
 This summary was machine generated May 10 at 14:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)